FI20105824A0 - Veriryhmästatuksen käyttö IV - Google Patents

Veriryhmästatuksen käyttö IV

Info

Publication number
FI20105824A0
FI20105824A0 FI20105824A FI20105824A FI20105824A0 FI 20105824 A0 FI20105824 A0 FI 20105824A0 FI 20105824 A FI20105824 A FI 20105824A FI 20105824 A FI20105824 A FI 20105824A FI 20105824 A0 FI20105824 A0 FI 20105824A0
Authority
FI
Finland
Prior art keywords
blood group
group status
status
blood
group
Prior art date
Application number
FI20105824A
Other languages
English (en)
Swedish (sv)
Inventor
Pirjo Wacklin
Jaana Maettoe
Harri Maekivuokko
Jukka Partanen
Original Assignee
Suomen Punainen Risti Veripalv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalv filed Critical Suomen Punainen Risti Veripalv
Priority to FI20105824A priority Critical patent/FI20105824A0/fi
Publication of FI20105824A0 publication Critical patent/FI20105824A0/fi
Priority to US13/812,580 priority patent/US20130230859A1/en
Priority to PCT/FI2011/050675 priority patent/WO2012013862A1/en
Priority to EP11811888.4A priority patent/EP2603230A4/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/02—Nutritional disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
FI20105824A 2010-07-26 2010-07-26 Veriryhmästatuksen käyttö IV FI20105824A0 (fi)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FI20105824A FI20105824A0 (fi) 2010-07-26 2010-07-26 Veriryhmästatuksen käyttö IV
US13/812,580 US20130230859A1 (en) 2010-07-26 2011-07-26 Use of blood group status
PCT/FI2011/050675 WO2012013862A1 (en) 2010-07-26 2011-07-26 Use of blood group status
EP11811888.4A EP2603230A4 (en) 2010-07-26 2011-07-26 USE OF BLOOD GROUP STATUS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20105824A FI20105824A0 (fi) 2010-07-26 2010-07-26 Veriryhmästatuksen käyttö IV

Publications (1)

Publication Number Publication Date
FI20105824A0 true FI20105824A0 (fi) 2010-07-26

Family

ID=42555517

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20105824A FI20105824A0 (fi) 2010-07-26 2010-07-26 Veriryhmästatuksen käyttö IV

Country Status (4)

Country Link
US (1) US20130230859A1 (fi)
EP (1) EP2603230A4 (fi)
FI (1) FI20105824A0 (fi)
WO (1) WO2012013862A1 (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020508700A (ja) * 2017-03-03 2020-03-26 ビオミレニア ソシエテ パ アクシオンス シンプリフィエ 細胞を培養し、試験するための微粒子

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1531832B1 (en) * 2002-06-28 2009-04-15 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
WO2005007834A1 (en) * 2003-07-23 2005-01-27 Probionic Corp. Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
CA2588991C (en) * 2004-12-01 2014-08-12 Meiji Dairies Corporation Human abo blood group-binding lactobacilli
ITRM20060369A1 (it) * 2006-07-17 2008-01-18 Giuliani Spa Miscela di batteri lattici per la preparazione di prodotti da forno senza glutine
CA2698374C (en) * 2007-09-07 2018-04-03 Children's Hospital Medical Center Use of secretor, lewis and sialyl antigen levels as predictors for disease
JP2010047504A (ja) * 2008-08-20 2010-03-04 Nippon Meat Packers Inc アトピー性皮膚炎緩和剤
US9603876B2 (en) * 2008-09-25 2017-03-28 New York University Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
FI20096402A0 (fi) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö II

Also Published As

Publication number Publication date
EP2603230A4 (en) 2014-12-10
WO2012013862A1 (en) 2012-02-02
US20130230859A1 (en) 2013-09-05
EP2603230A1 (en) 2013-06-19

Similar Documents

Publication Publication Date Title
FI20105825A (fi) Veriryhmästatuksen käyttö III
BR112012017375A2 (pt) artigo descartável do vestuário
DK2384731T3 (da) Medicinsk behandlingsvogn
DK3162386T3 (da) Implanterbare medicinske indretninger
DK2593060T3 (da) Engangsble
FI20105639A (fi) Mikroselluloosan valmistus
BR112014004434A2 (pt) cateter biocompatível
CU23987B1 (es) Equipo médico
FI20105335A0 (fi) Sydämen sykkeen havainnointi
FI20096402A0 (fi) Veriryhmästatuksen käyttö II
DK2590565T3 (da) Blodprøvetagning
FI20106249A0 (fi) Kertakäyttöinen sydämen sykkeenilmaisin
DK2600881T3 (da) Naturlig medicinsk forbindelse
FR2965717B1 (fr) Fauteuil roulant
FR2965715B1 (fr) Fauteuil roulant
FR2956419B1 (fr) Elements de construction calorifuges
FI20105824A0 (fi) Veriryhmästatuksen käyttö IV
FR2967355B1 (fr) Seringue dentaire securisee
PL395785A1 (pl) Zastosowanie medyczne N-etylo-3-amino-4-fenylo-5-okso-2,5-dihydro-1H-pirazolo-1-karbotioamidu
FI20105670A (fi) ABO-tyypin käyttö
FR2955136B1 (fr) Arret de vantail
FI20100324A0 (fi) Vastavoiman hyödyksikäyttö
FI20100084A0 (fi) Vastavoiman hyödyksikäyttö
FI20095511A0 (fi) Lääkeaineen uusi käyttö
TH114583B (th) กระบอกฉีดยา

Legal Events

Date Code Title Description
FD Application lapsed